Home › Funds › BRAIDWELL LP › MAZE

BRAIDWELL LP position in MAZE

MAZE THERAPEUTICS INC COM · Health Care

BRAIDWELL LP reported holding 1,140,040 shares of MAZE (MAZE THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$34.0M, representing 1.34% of its reported portfolio and ranking #27 among its reported holdings. BRAIDWELL LP first reported this position in Q2 2026.

Latest position (Q2 2026)1.14M sh
Reported value held$34.02M
Portfolio Weight1.34%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BRAIDWELL LP's MAZE position evolved

BRAIDWELL LP first disclosed a stake in MAZE in Q2 2026 at 1,140,040 shares (US$34.0M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.14M $34.02M New

About MAZE and 13F data

MAZE (MAZE THERAPEUTICS INC COM) is a Health Care company. 74 other funds we track also report a position in MAZE — the largest reported positions include Frazier Life Sciences Management, L.P. (US$150.2M), TRV GP IV, LLC (US$133.5M), ARCH Venture Management, LLC (US$123.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MAZE

All MAZE fund holders →

FAQ

How long has BRAIDWELL LP held MAZE?

BRAIDWELL LP has disclosed MAZE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is BRAIDWELL LP's current position in MAZE?

As of Q2 2026, BRAIDWELL LP holds 1.14M shares of MAZE (MAZE THERAPEUTICS INC COM), valued at $34.02M, representing 1.34% of its reported portfolio and ranking #27.

Has BRAIDWELL LP been buying or selling MAZE?

In the latest 13F filing (Q2 2026), BRAIDWELL LP newly opened its position in MAZE.

Which other funds hold MAZE?

Other major institutional holders of MAZE include Frazier Life Sciences Management, L.P., TRV GP IV, LLC, ARCH Venture Management, LLC, among 74 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.